Tidewater Clinical Research
Welcome,         Profile    Billing    Logout  
 6 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gala, Rajiv B
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
Miller, Charles E
NCT05394662: Safety and Effectiveness of Juveena™ Hydrogel System Following TCGP At High-Risk for Intrauterine Adhesions

Recruiting
3
150
US
Juveena Hydrogel System
Rejoni Inc.
Intrauterine Adhesion
03/25
03/25
BRUNELLO, NCT06571045: A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Recruiting
2/3
960
Europe, US, RoW
Ranibizumab, Lucentis, EYE103, Restoret
EyeBiotech Ltd.
Diabetic Macular Edema (DME)
12/27
12/27
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
TITAN:SvS, NCT03536312: Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

Recruiting
N/A
610
Canada, US
Thoracic Aortic Surgery
Ottawa Heart Institute Research Corporation, University of Calgary
Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
05/25
05/26
Morgan, Franklin
NCT04209543 / 2019-001289-14: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Completed
3
1570
Europe, Canada, US, RoW
Estetrol, Placebo, Progesterone
Estetra, ICON Clinical Research
Vasomotor Symptoms, Menopausal Symptoms
02/24
02/24
MERMAID, NCT06121063: CCT-102 or Expectant Management in Delayed Pregnancy Loss

Recruiting
3
160
US
CCT-102 A and CCT-102 B
Conceptra Biosciences, LLC
Early Pregnancy Loss, Delayed Pregnancy Loss
12/24
12/24
NCT05101317: A Study to Assess the Efficacy and Safety of HMI-115 in Subjects with Endometriosis-Associated Pain

Recruiting
2
152
Europe, US, RoW
HMI-115, Placebo
Hope Medicine (Nanjing) Co., Ltd
Endometriosis
12/24
04/25
Rusch, April
NCT05139121: Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Completed
3
1319
Canada, US
MR-100A-01, Transdermal contraceptive delivery system
Mylan Technologies Inc., Mylan Inc.
Contraception
01/25
01/25
MERMAID, NCT06121063: CCT-102 or Expectant Management in Delayed Pregnancy Loss

Recruiting
3
160
US
CCT-102 A and CCT-102 B
Conceptra Biosciences, LLC
Early Pregnancy Loss, Delayed Pregnancy Loss
12/24
12/24
NCT03942419: Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression

Terminated
3
438
US
Atropine 0.1% Ophthalmic Solution, Atropine 0.01% Ophthalmic Solution, Placebo Ophthalmic Solution
Eyenovia Inc.
Myopia
10/24
11/24
NCT05096065: Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

Recruiting
2
16
US
Leuprolide Oral Tablet - 120 mg - QD- Treatment A, Ovarest® 60 mg, Leuprolide Oral Tablet - 80 mg - QD - Treatment B, Ovarest® 40 mg, Leuprolide Oral Tablet - 60 mg - QD - Treatment C, Leuprolide Oral Tablet - 60 mg - BID - Treatment D, Leuprolide Oral Tablet - 40 mg - BID - Treatment E
Enteris BioPharma Inc., Parexel, Syneos Health
Endometriosis
05/22
05/22
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
ZIMS, NCT05570916: Zip-Stitch® in Minimally-Invasive Surgery () - Safety & Efficacy in Hysterectomy

Active, not recruiting
N/A
59
US
Zip-stitch(R), Reference suture, V-Loc or VICRYL sutures
ZSX Medical LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Laparoscopic Hysterectomy
06/24
05/25
Rodriguez, Alison
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25

Download Options